| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |